The Union Ministry of AYUSH has taken suo moto cognizance of the media reports about Patanjali corona medicine or Ayurvedic medicines developed by Patanjali Ayurved Ltd. for treatment of Covid-19. The Ministry has asked the company to refrain from making such claims until they are duly verified by the concerned authorities.
The Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19.
For the purposes of verification, the Government has asked Patanjali Ayurved to disclose the following in case of patanjali corona medicine:
- the name and composition of the medicines being claimed for COVID treatment;
- site(s)/hospital(s), where the research study was conducted for COVID-19;
- protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study(ies).
The Ministry had issued a Gazette Notification on April 21, 2020, stipulating all the requirements and the manner in which the research studies on COVID-19 have to be undertaken, with Ayush interventions/medicines.
Also Read : [Patanjali] Temporary Restrain on APN Live From Airing Defamatory Content Against Patanjali Ayurved : Delhi HC
Yog Guru Ramdev explaining about patanjali corona medicine claimed at a press conference today,
“We are launching COVID medicines Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this 280 patients were included and 100 per cent of those recovered. We were able to control Corona and its complications in this. After this the all-important clinical control trial was conducted.”